The global cancer biomarkers market has seen remarkable growth and is expected to continue expanding in the coming years. Valued at USD 15.8 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2025 to 2034, reaching USD 52.4 billion by 203